UBS Group Analysts Give Allianz (ALV) a €220.00 Price Target

Share on StockTwits

UBS Group set a €220.00 ($255.81) price target on Allianz (FRA:ALV) in a research report released on Tuesday, October 16th, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

A number of other analysts have also recently weighed in on the stock. JPMorgan Chase & Co. set a €219.00 ($254.65) price target on shares of Allianz and gave the stock a buy rating in a research report on Monday, October 8th. Deutsche Bank set a €220.00 ($255.81) price objective on shares of Allianz and gave the stock a buy rating in a report on Tuesday, October 2nd. equinet set a €220.00 ($255.81) price objective on shares of Allianz and gave the stock a buy rating in a report on Wednesday, September 12th. BNP Paribas set a €205.00 ($238.37) price objective on shares of Allianz and gave the stock a neutral rating in a report on Tuesday, September 11th. Finally, Barclays set a €210.00 ($244.19) price objective on shares of Allianz and gave the stock a neutral rating in a report on Friday, September 7th. Thirteen equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus target price of €210.54 ($244.81).

Allianz stock traded up €4.98 ($5.79) during trading on Tuesday, reaching €192.00 ($223.26). 2,168,274 shares of the company’s stock were exchanged. Allianz has a 52-week low of €167.30 ($194.53) and a 52-week high of €206.80 ($240.47).

Allianz Company Profile

Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide. The company's Property-Casualty segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel insurance products to private and corporate customers.

Further Reading: Cash Flow

Analyst Recommendations for Allianz (FRA:ALV)

Receive News & Ratings for Allianz Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allianz and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.